Table of Contents page: Journal of Hepatology

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Editorial Board

Published in issue: May 2012

i

EASL Physician Scientist Fellowships

Published in issue: May 2012

vi

iLiver app for iPhone and iPad

Published in issue: May 2012

vii

EASL Monothematic Conference Tallinn, Estonia, June 2012

Published in issue: May 2012

viii

EASL Special Conference, Prague, the Czech Republic, September 2012

Published in issue: May 2012

ix

EASL Clinical School: Liver transplantation and acute liver failure, London, UK, December 14, 2012

Published in issue: May 2012

xiv

Focus

Scott L. Friedman

Published online: February 07, 2012

p1001-1002

Open Access

Mechanistic biomarkers in acute liver injury: Are we there yet?

Danielle Adebayo,
Rajeshwar P. Mookerjee,
Rajiv Jalan

Published online: February 09, 2012

p1003-1005

Open Access

Research Articles

Viral Hepatitis

Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a

Vincent Rijckborst,
Bettina E. Hansen,
Peter Ferenci,
...
Massimo Colombo,
Harry L.A. Janssen,
Pietro Lampertico

Published online: January 16, 2012

p1006-1011

A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C

Pham Thi Thu Thuy,
Chalermrat Bunchorntavakul,
Ho Tan Dat,
K. Rajender Reddy

Published online: January 18, 2012

p1012-1018

Understanding silibinin’s modes of action against HCV using viral kinetic modeling

Jeremie Guedj,
Harel Dahari,
Ralf T. Pohl,
Peter Ferenci,
Alan S. Perelson

Published online: January 16, 2012

p1019-1024

Cirrhosis

Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: A randomized controlled trial

Hung-Hsu Hung,
Chen-Jung Chang,
Ming-Chih Hou,
...
Han-Chieh Lin,
Fa-Yauh Lee,
Shou-Dong Lee

Published online: January 18, 2012

p1025-1032

PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats

Aina Rodríguez-Vilarrupla,
Bàrbara Laviña,
Héctor García-Calderó,
...
Núria Roglans,
Jaume Bosch,
Joan Carles García-Pagán

Published online: January 16, 2012

p1033-1039

Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study

Gustavo Pereira,
Mónica Guevara,
Claudia Fagundes,
...
Marco Pavesi,
Vicente Arroyo,
Pere Ginès

Published online: January 16, 2012

p1040-1046

Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression

Naina Shah,
Dipok Dhar,
Fatma El Zahraa Mohammed,
...
Steven W.M. Olde Damink,
Rajeshwar P. Mookerjee,
Rajiv Jalan

Published online: January 18, 2012

p1047-1053

The impact of organ dysfunction in cirrhosis: Survival at a cost?

Debbie L. Shawcross,
Mark J. Austin,
Robin Daniel Abeles,
...
Elizabeth Sizer,
William Bernal,
Julia A. Wendon

Published online: January 16, 2012

p1054-1062

Transplantation

High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis

Sven Pischke,
Juliane Gösling,
Ilka Engelmann,
...
Thomas Schulz,
Heiner Wedemeyer,
Albert Heim

Published online: January 16, 2012

p1063-1069

Liver Failure and Growth

RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity

Daniel J. Antoine,
Rosalind E. Jenkins,
James W. Dear,
...
Kenneth J. Simpson,
Hartmut Jaeschke,
B. Kevin Park

Published online: January 18, 2012

p1070-1079

Cancer

Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses

Jean-Luc Raoul,
Jordi Bruix,
Tim F. Greten,
...
Marius Moscovici,
Dimitris Voliotis,
Josep M. Llovet

Published online: January 16, 2012

p1080-1088

Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population

Alessandro Cucchetti,
Franco Trevisani,
Matteo Cescon,
...
Maria Chiaramonte,
Antonio Daniele Pinna
for the Italian Liver Cancer (ITA.LI.CA) Group

Published online: January 16, 2012

p1089-1096

Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study

Chiun Hsu,
Tsai-Sheng Yang,
Teh-Ia Huo,
...
Yee Chao,
Robin Meng,
Ann-Lii Cheng

Published online: January 16, 2012

p1097-1103

A novel biliary stent loaded with 125I seeds in patients with malignant biliary obstruction: Preliminary results versus a conventional biliary stent

A novel biliary stent loaded with ¹²⁵I seeds in patients with malignant biliary obstruction: Preliminary results versus a conventional biliary stent

Hai-Dong Zhu,
Jin-He Guo,
Guang-Yu Zhu,
...
Guo-Zhao Li,
Douglas M. Coldwell,
Gao-Jun Teng

Published online: January 18, 2012

p1104-1111

Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis

Khairuddin Memon,
Laura Kulik,
Robert J. Lewandowski,
...
Mary F. Mulcahy,
Reed A. Omary,
Riad Salem

Published online: January 16, 2012

p1112-1120

Assessment of pathology reports on hilar cholangiocarcinoma: The results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group

Denis Chatelain,
Olivier Farges,
David Fuks,
Nathalie Trouillet,
François René Pruvot,
Jean-Marc Regimbeau

Published online: January 16, 2012

p1121-1128

Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma

Masafumi Shimoda,
Yoshito Tomimaru,
Kevin P. Charpentier,
Howard Safran,
Rolf I. Carlson,
Jack Wands

Published online: January 16, 2012

p1129-1135

Cholestasis and Autoimmune Diseases

4-Phenylbutyrate modulates ubiquitination of hepatocanalicular MRP2 and reduces serum total bilirubin concentration

Hisamitsu Hayashi,
Tadahaya Mizuno,
Reiko Horikawa,
...
Takashi Yabuki,
Hajime Takikawa,
Yuichi Sugiyama

Published online: January 16, 2012

p1136-1144

Genetic and Metabolic Diseases

Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up

Shira Zelber-Sagi,
Roni Lotan,
Amir Shlomai,
...
Dorit Nitzan Kaluski,
Zamir Halpern,
Ran Oren

Published online: January 16, 2012

p1145-1151

Structural and inflammatory heterogeneity in subcutaneous adipose tissue: Relation with liver histopathology in morbid obesity

Joan Tordjman,
Adeline Divoux,
Edi Prifti,
...
Pierre Bedossa,
Michèle Guerre-Millo,
Karine Clement

Published online: January 16, 2012

p1152-1158

Development of the bile ducts: Essentials for the clinical hepatologist

Mario Strazzabosco,
Luca Fabris

Published online: January 16, 2012

p1159-1170

Open Access

Clinical evidence for the regression of liver fibrosis

Elizabeth L. Ellis,
Derek A. Mann

Published online: January 16, 2012

p1171-1180

Open Access

Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

Kirsten Boonstra,
Ulrich Beuers,
Cyriel Y. Ponsioen

Published online: January 16, 2012

p1181-1188

Open Access

Frontiers in Liver Transplantation

The option of HBIG-free prophylaxis against recurrent HBV

Alyson N. Fox,
Norah A. Terrault

Published online: January 23, 2012

p1189-1197

Open Access

International Hepatology

Cell population genetics and deep sequencing: A novel approach for drivers discovery in hepatocellular carcinoma

Clara Alsinet,
Augusto Villanueva,
Josep M. Llovet

Published online: December 14, 2011

p1198-1200

Open Access

It’s not all in the cilium, but on the road to it: Genetic interaction network in polycystic kidney and liver diseases and how trafficking and quality control matter

Carsten Bergmann,
Ralf Weiskirchen

Published online: November 29, 2011

p1201-1203

Open Access

Hepatology Snapshot

Histamine regulation of biliary proliferation

Heather Francis,
Fanyin Meng,
Eugenio Gaudio,
Gianfranco Alpini

Published online: January 16, 2012

p1204-1206

Open Access

Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitis

Tony Bruns,
Philipp A. Reuken,

Janett Fischer,
Thomas Berg,

Andreas Stallmach

Published online: October 21, 2011

p1207-1208

Open Access

Reply to: “Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitis”

Hans Dieter Nischalke,

Frank Grünhage,

Ulrich Spengler,

Beate Appenrodt

Published online: October 21, 2011

p1208-1209

Open Access

Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients

Luca Valenti,

Alessio Aghemo,

Albert Friedrich Stättermayer

Published online: January 09, 2012

p1209-1210

Open Access

Reply to: “Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients”

Eric Trépo,

Pierre Pradat,

Jeanette J. McCarthy,

Hans L. Tillmann

Published online: January 09, 2012

p1210-1212

Open Access

The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on

Godhev K. Manakkat Vijay,
Nicholas J. Taylor,
Debbie Lindsay Shawcross

Published online: November 28, 2011

p1212-1213

Open Access

Reply to: “The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on”

Giovanni Tritto,
Rajeshwar P Mookerjee,
Rajiv Jalan

Published online: November 29, 2011

p1213-1214

Open Access

2′,7′-Dichlorofluorescein is not a probe for the detection of reactive oxygen and nitrogen species

Megan J. Reiniers,

Rowan F. van Golen,
Thomas M. van Gulik,

Michal Heger

Published online: November 28, 2011

p1214-1216

Open Access

Reply to: “2′,7′-Dichlorofluorescein is not a probe for the detection of reactive oxygen and nitrogen species”

Albert Morales,
Carmen Garcia-Ruiz,

Jose C. Fernandez-Checa

Published online: November 28, 2011

p1216-1217

Open Access

Erratum to: “Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin” [J Hepatol 2012;56:34–40]

Chung-Feng Huang,
Jee-Fu Huang,
Jeng-Fu Yang,
...
Hsing-Tao Kuo,
Chia-Yen Dai,
Ming-Lung Yu

Published online: February 21, 2012

p1218

May 2012

Focus

Editorial

Research Articles

Viral Hepatitis

Cirrhosis

Transplantation

Liver Failure and Growth

Cancer

Cholestasis and Autoimmune Diseases

Genetic and Metabolic Diseases

Reviews

Special Sections

Frontiers in Liver Transplantation

International Hepatology

Hepatology Snapshot

Letters to the Editor

Erratum